UniteLabs has raised $3.0M in total across 1 funding round.
UniteLabs's investors include Cavalry Ventures, Sequoia Capital, Paul Forster.
UniteLabs is a Munich-based technology company founded in 2022 that builds an operating system for AI-powered laboratory automation in the life sciences sector[1][2][3]. Its platform connects diverse lab hardware and software via vendor-agnostic bidirectional interfaces, a scalable cloud with open APIs, and a workflow engine, enabling "lab-as-code" automation with a Python SDK for modular workflows[1][2][3]. It serves ambitious biotech firms, large pharma companies, integrators, and hardware vendors, solving fragmentation in lab operations—such as manual liquid handling bottlenecks and siloed devices—by providing real-time control, data capture, and remote experiment design/execution to accelerate R&D breakthroughs[1][2][3][6]. With 40+ connectors already built and plans to reach 650 instruments, the company shows strong early momentum through pilot customers and team expansion[2].
UniteLabs was founded in 2022 in München, Germany, by Co-CEOs Robert Zechlin and Lukas Bromig, alongside CTO Julian Willand, who bring expertise in chemical engineering, information systems, and business strategy[2][4]. The idea emerged from frustration with "broken systems, outdated tools, and lab workarounds" that fragment environments and hinder discovery, prompting the team—engineers and scientists—to build foundational infrastructure instead of patchwork fixes[3][4]. Early traction includes developing 40 connectors for lab devices like liquid handlers (key for experiments from COVID testing to DNA sequencing), establishing cross-manufacturer connectivity, and securing pilot customers while planning team doubling[2].
UniteLabs rides the AI-biotech convergence trend, where lab automation demands grow amid rising R&D costs and data explosion in drug discovery, genomics, and personalized medicine[1][2]. Timing is ideal as manual bottlenecks persist despite advances in robotics, with market forces like big pharma's push for efficiency (e.g., faster COVID/DNA workflows) favoring interoperable platforms over siloed tools[2]. It influences the ecosystem by enabling "cloud-ready labs," fostering cross-vendor collaboration, and setting standards for data infrastructure—potentially accelerating breakthroughs while reducing waste in a $100B+ lab automation market[1][3].
UniteLabs is poised to dominate lab OS space by expanding connectors to 650+ instruments and deepening AI integrations for predictive workflows[2][3]. Trends like edge-to-cloud lab digitization and modular automation will propel growth, especially as biotech scales post-2025 funding waves. Its influence may evolve from connector pioneer to ecosystem orchestrator, powering "launchpad labs" that unblock discovery at scale—transforming fragmented R&D into interconnected progress, much like cloud unified computing[1][4].
UniteLabs has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in April 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2025 | $3.0M Seed | Cavalry Ventures, Sequoia Capital, Paul Forster |
